Potential Drug Target Or Breast Cancer Biomarker SCCPDH (G51097)

Target Name: SCCPDH

NCBI ID: G51097

Potential Drug Target Or Breast Cancer Biomarker SCCPDH

SCCPDH (stimulated cancer cell proliferation-derived hybridoma) is a protein that is expressed in various types of cancer cells. It is also known as OTTHUMP00000038085. SCCPDH is a potential drug target or biomarker for various types of cancer.

SCCPDH is a transcription factor that plays a role in the regulation of cell proliferation. It is expressed in various types of cancer cells, including lung, breast, and ovarian cancer cells. It is also found in normal tissues, such as the skin and the uterus.

SCCPDH has been shown to promote the growth and proliferation of cancer cells. It is also associated with the development of various types of cancer, including breast cancer.

SCCPDH is a potential drug target because it is involved in the regulation of cell proliferation. This makes it an attractive target for cancer treatments because it can be inhibited using small molecules or antibodies.

SCCPDH is also a potential biomarker for cancer. Because it is expressed in various types of cancer, it can be used as a potential biomarker for cancer.

Currently, scientists are exploring SCCPDH's potential as a drug target or biomarker. There have been some studies showing that SCCPDH can be used as a new method to treat various cancers.

However, at present, in-depth research on SCCPDH still needs to be further understood. More studies are needed to determine SCCPDH's pharmacological effects and value as a cancer biomarker.

SCCPDH is a protein expressed in a variety of cancers and is known for promoting cancer cell growth and proliferation. Therefore, it is a potential drug target or biomarker for breast cancer. In the future, scientists will continue to study SCCPDH in depth to determine its pharmacological effects and evaluate its value in cancer treatment.

Protein Name: Saccharopine Dehydrogenase (putative)

More Common Targets